These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 21941466)

  • 1. Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseases.
    Beurel E
    Front Mol Neurosci; 2011; 4():18. PubMed ID: 21941466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3).
    Beurel E; Michalek SM; Jope RS
    Trends Immunol; 2010 Jan; 31(1):24-31. PubMed ID: 19836308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinase 3: a point of convergence for the host inflammatory response.
    Wang H; Brown J; Martin M
    Cytokine; 2011 Feb; 53(2):130-40. PubMed ID: 21095632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase kinase-3 regulates inflammatory tolerance in astrocytes.
    Beurel E; Jope RS
    Neuroscience; 2010 Sep; 169(3):1063-70. PubMed ID: 20553816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Convergence of the mammalian target of rapamycin complex 1- and glycogen synthase kinase 3-β-signaling pathways regulates the innate inflammatory response.
    Wang H; Brown J; Gu Z; Garcia CA; Liang R; Alard P; Beurel E; Jope RS; Greenway T; Martin M
    J Immunol; 2011 May; 186(9):5217-26. PubMed ID: 21422248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity.
    Yuskaitis CJ; Jope RS
    Cell Signal; 2009 Feb; 21(2):264-73. PubMed ID: 19007880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase 3-β: a master regulator of toll-like receptor-mediated chronic intestinal inflammation.
    Hofmann C; Dunger N; Schölmerich J; Falk W; Obermeier F
    Inflamm Bowel Dis; 2010 Nov; 16(11):1850-8. PubMed ID: 20848477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain.
    Beurel E; Jope RS
    J Neuroinflammation; 2009 Mar; 6():9. PubMed ID: 19284588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.
    Beurel E; Grieco SF; Jope RS
    Pharmacol Ther; 2015 Apr; 148():114-31. PubMed ID: 25435019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells.
    Beurel E; Yeh WI; Michalek SM; Harrington LE; Jope RS
    J Immunol; 2011 Feb; 186(3):1391-8. PubMed ID: 21191064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics.
    Jope RS; Yuskaitis CJ; Beurel E
    Neurochem Res; 2007; 32(4-5):577-95. PubMed ID: 16944320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments.
    King MK; Pardo M; Cheng Y; Downey K; Jope RS; Beurel E
    Pharmacol Ther; 2014 Jan; 141(1):1-12. PubMed ID: 23916593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3 promotes T helper type 17 differentiation by promoting interleukin-9 production.
    Han D; Medina-Rodriguez EM; Lowell JA; Beurel E
    Immunology; 2020 Aug; 160(4):357-365. PubMed ID: 32277469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in the Therapeutic Potential of Inhibitors Targeting Glycogen Synthase Kinase 3 in Inflammatory Diseases.
    Zhu Y; Wang H; Guo Y; Cao J; Li H
    Mini Rev Med Chem; 2023; 23(19):1893-1904. PubMed ID: 37055897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium controls central nervous system autoimmunity through modulation of IFN-γ signaling.
    Rowse AL; Naves R; Cashman KS; McGuire DJ; Mbana T; Raman C; De Sarno P
    PLoS One; 2012; 7(12):e52658. PubMed ID: 23285134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of inflammation and T cells by glycogen synthase kinase-3: links to mood disorders.
    Beurel E
    Neuroimmunomodulation; 2014; 21(2-3):140-4. PubMed ID: 24557047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stressed and Inflamed, Can GSK3 Be Blamed?
    Jope RS; Cheng Y; Lowell JA; Worthen RJ; Sitbon YH; Beurel E
    Trends Biochem Sci; 2017 Mar; 42(3):180-192. PubMed ID: 27876551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of STAT family members by glycogen synthase kinase-3.
    Beurel E; Jope RS
    J Biol Chem; 2008 Aug; 283(32):21934-44. PubMed ID: 18550525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3.
    Martin M; Rehani K; Jope RS; Michalek SM
    Nat Immunol; 2005 Aug; 6(8):777-84. PubMed ID: 16007092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
    Wang D; Lu Z; Zhang H; Jin SF; Yang H; Li YM; Shi LY
    CNS Neurosci Ther; 2016 Jul; 22(7):558-67. PubMed ID: 27013083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.